Journal of Advanced Biomedical Sciences
JABS
Fri, May 3, 2024
[Archive]
Winter 2024(In Press)
Back to the articles list |
Back to browse issues page
1- Research Center for Herbal Medicine and Complementary Medicine, Alborz University of Medical Sciences, Karaj, Iran
2- Department of Basic Science, Faculty of Veterinary Medicine, Tehran University, Tehran, Iran , hmorovati@ut.ac.ir
3- Physiology Research Center, Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
2- Department of Basic Science, Faculty of Veterinary Medicine, Tehran University, Tehran, Iran , hmorovati@ut.ac.ir
3- Physiology Research Center, Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
Abstract: (277 Views)
Background & Objectives: Kelussia odoratissima is involved in the treatment of kidney stones, irritation of the urinary tract and kidney and bladder cleansing. It is useful for gout patients and is used to treat kidney and ureteral stones. The aim of this study was to investigate the effect of Kelussia odoratissima on renal function tests in male rats.
Materials & Methods: In this study, 20 rats were randomly divided into one control group and three treatment groups (n=5 per group). The treatment groups received a 40, 80, and 120 mg/kg silver nanoparticles produced by the extracts of Kelussia, orally once a day for 6 days. After taking a blood sample, a kidney function test was performed. SPSS software version 21 was used for data collection, and the results were presented as mean and standard deviation (mean±SEM).
Results: Oral administration of silver nanoparticles produced by Kelussia extracts at 80 mg/kg dose significantly reduced bilirubin and urea compared to the control group (P<0.05). The 120 mg/kg dose also significantly reduced urea compared to the control group (P<0.05). There was no significant effect on total protein, albumin and urea.
Conclusion: Silver nanoparticles produced by the Kelussia extracts did not show any negative effect on kidney function, but had some positive effect on waste removal.
Materials & Methods: In this study, 20 rats were randomly divided into one control group and three treatment groups (n=5 per group). The treatment groups received a 40, 80, and 120 mg/kg silver nanoparticles produced by the extracts of Kelussia, orally once a day for 6 days. After taking a blood sample, a kidney function test was performed. SPSS software version 21 was used for data collection, and the results were presented as mean and standard deviation (mean±SEM).
Results: Oral administration of silver nanoparticles produced by Kelussia extracts at 80 mg/kg dose significantly reduced bilirubin and urea compared to the control group (P<0.05). The 120 mg/kg dose also significantly reduced urea compared to the control group (P<0.05). There was no significant effect on total protein, albumin and urea.
Conclusion: Silver nanoparticles produced by the Kelussia extracts did not show any negative effect on kidney function, but had some positive effect on waste removal.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)